These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2788422)

  • 1. Differential deoxyadenosine toxicity to immature rabbit cartilage in vitro. A model for the chondro-osseous dysplasia of adenosine deaminase deficiency.
    Wortmann RL; Veum JA; Ryan LM; Cheung HS
    Arthritis Rheum; 1989 Aug; 32(8):1014-21. PubMed ID: 2788422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine deaminase deficiency and chondro-osseous dysplasia.
    Wortmann RL; Veum JA; Cheung HS
    Adv Exp Med Biol; 1986; 195 Pt A():81-3. PubMed ID: 3487928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis for the chondro-osseous dysplasia associated with adenosine deaminase deficiency: selective toxicity to immature chondrocytes.
    Wortmann RL; Tekkanat KK; Veum JA; Meyer RA; Hood JO; Horton WA
    Adv Exp Med Biol; 1991; 309B():265-8. PubMed ID: 1781380
    [No Abstract]   [Full Text] [Related]  

  • 4. Purine metabolism in adenosine deaminase deficiency.
    Simmonds HA; Sahota A; Potter CF; Perrett D; Hugh-Jones K; Watson JG
    Ciba Found Symp; 1978; (68):255-62. PubMed ID: 387357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.
    Ratech H; Greco MA; Gallo G; Rimoin DL; Kamino H; Hirschhorn R
    Am J Pathol; 1985 Jul; 120(1):157-69. PubMed ID: 4014441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
    Chan TS
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
    Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
    Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine- and deoxyadenosine-mediated altered pyrimidine metabolism in human adeosine deaminase-deficient lymphoblasts.
    Parker NF; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1982 May; 99(5):731-9. PubMed ID: 6175708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
    Cowan MJ; Shannon KM; Wara DW; Ammann AJ
    Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal relationship between erythrocyte ATP and deoxy-ATP levels in inherited ADA deficiency.
    Simmonds HA; Levinsky RJ; Perrett D; Webster DR
    Biochem Pharmacol; 1982 Mar; 31(6):947-51. PubMed ID: 7082375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency.
    Cederbaum SD; Kaitila I; Rimoin DL; Stiehm ER
    J Pediatr; 1976 Nov; 89(5):737-42. PubMed ID: 978320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.
    Hirschhorn R; Roegner-Maniscalco V; Kuritsky L; Rosen FS
    J Clin Invest; 1981 Dec; 68(6):1387-93. PubMed ID: 7033281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
    Albert D; Bluestein HG; Thompson L; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine dysfunction in cells from patients with adenosine deaminase deficiency.
    Benke PJ; Dittmar D
    Pediatr Res; 1976 Jul; 10(7):642-6. PubMed ID: 132630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroosseous histopathology in adenosine deaminase deficient combined immunodeficiency disease.
    Kaitila I; Rimoin DL; Cedarbaum SD; Stiehm ER; Lachman RS
    Birth Defects Orig Artic Ser; 1976; 12(6):115-21. PubMed ID: 974246
    [No Abstract]   [Full Text] [Related]  

  • 20. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
    Kubota M; Carrera CJ; Wasson DB; Carson DA
    Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.